» Articles » PMID: 6693948

Identification and Purification of Glial Growth Factor

Overview
Journal J Neurosci
Specialty Neurology
Date 1984 Jan 1
PMID 6693948
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Cultured rat Schwann cells are stimulated to divide by a protein growth factor, present in extracts of bovine brain and pituitary, which we have named glial growth factor (GGF). Two lines of evidence indicate that GGF activity in both brain and pituitary resides in a protein of Mr = 31,000. (1) Four independently isolated monoclonal antibodies that immunoprecipitate the activity react with an antigen of this molecular weight in sodium dodecyl sulfate (SDS)-polyacrylamide gels. (2) After SDS-polyacrylamide gel electrophoresis of partially purified preparations, mitogenic activity on Schwann cells is recovered at this molecular weight. GGF has been purified approximately 10(5)-fold to apparent homogeneity from bovine pituitary anterior lobes by a combination of column chromatography steps and preparative SDS gel electrophoresis. Purified human platelet-derived growth factor, a molecule with properties similar to those of GGF, is inactive on Schwann cells and therefore appears to be distinct.

Citing Articles

Injury-induced Neuregulin-ErbB signaling from muscle mobilizes stem cells for whole-body regeneration in Acoels.

Stevens B, Popp R, Valera H, Krueger K, Petersen C bioRxiv. 2025; .

PMID: 39764063 PMC: 11703163. DOI: 10.1101/2024.12.23.630141.


Development and In Vitro Differentiation of Schwann Cells.

Horner S, Couturier N, Gueiber D, Hafner M, Rudolf R Cells. 2022; 11(23).

PMID: 36497014 PMC: 9739763. DOI: 10.3390/cells11233753.


Neuregulins in Neurodegenerative Diseases.

Ou G, Lin W, Zhao W Front Aging Neurosci. 2021; 13:662474.

PMID: 33897409 PMC: 8064692. DOI: 10.3389/fnagi.2021.662474.


Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?.

Chen C, Neumann B, Forster S, Franklin R Open Biol. 2021; 11(1):200352.

PMID: 33497588 PMC: 7881176. DOI: 10.1098/rsob.200352.


NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.

Laskin J, Liu S, Tolba K, Heining C, Schlenk R, Cheema P Ann Oncol. 2020; 31(12):1693-1703.

PMID: 32916265 PMC: 8911318. DOI: 10.1016/j.annonc.2020.08.2335.